Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Passeron

Showing results (1-10 of 289) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|July 13, 2020
First step in a new era for treatment of patients with vitiligoThierry Passeron
Dermatologic Clinics|March 21, 2017
Medical and Maintenance Treatments for VitiligoThierry Passeron
Journal of Dermatological Science|January 19, 2019
The key question of irradiance when it comes to the effects of visible light in the skinThierry Passeron
The British Journal of Dermatology|March 21, 2024
A pledge for a better care and consideration of patients with vitiligoThierry Passeron
JAMA Dermatology|January 22, 2015
Indications and limitations of afamelanotide for treating vitiligoThierry Passeron
Journal of the European Academy of Dermatology and Venereology : JEADV|October 25, 2023
Vitiligo, it was about time!Thierry Passeron
The Journal of Investigative Dermatology|July 12, 2023
Surgical Approaches for Repigmenting Vitiligo 2.0Thierry Passeron
Journal of the American Academy of Dermatology|August 21, 2013
Long-lasting effect of vascular targeted therapy of melasmaThierry Passeron
Annales De Dermatologie Et De Venereologie|June 1, 2010
[What is the impact of the new clinical trial data? What are the lessons for patient management?]Thierry Passeron, Serge Boulinguez
Pigment Cell & Melanoma Research|December 30, 2017
Melasma, a photoaging disorderThierry Passeron, Mauro Picardo
Pageof 29

Showing results (1-10 of 289) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|July 13, 2020
First step in a new era for treatment of patients with vitiligoThierry Passeron
Dermatologic Clinics|March 21, 2017
Medical and Maintenance Treatments for VitiligoThierry Passeron
Journal of Dermatological Science|January 19, 2019
The key question of irradiance when it comes to the effects of visible light in the skinThierry Passeron
The British Journal of Dermatology|March 21, 2024
A pledge for a better care and consideration of patients with vitiligoThierry Passeron
JAMA Dermatology|January 22, 2015
Indications and limitations of afamelanotide for treating vitiligoThierry Passeron
Journal of the European Academy of Dermatology and Venereology : JEADV|October 25, 2023
Vitiligo, it was about time!Thierry Passeron
The Journal of Investigative Dermatology|July 12, 2023
Surgical Approaches for Repigmenting Vitiligo 2.0Thierry Passeron
Journal of the American Academy of Dermatology|August 21, 2013
Long-lasting effect of vascular targeted therapy of melasmaThierry Passeron
Annales De Dermatologie Et De Venereologie|June 1, 2010
[What is the impact of the new clinical trial data? What are the lessons for patient management?]Thierry Passeron, Serge Boulinguez
Pigment Cell & Melanoma Research|December 30, 2017
Melasma, a photoaging disorderThierry Passeron, Mauro Picardo
Pageof 29